Jefferies Drops Coverage of Bio-Reference Labs (BRLI) After TheStreetSweeper Report
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Rating Summary:
0 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
0 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Jefferies dropped coverage of Bio-Reference Labs (Nasdaq: BRLI) due to increased
business uncertainties. The firm's latest rating was "Under Review" and our last price target was $21.
"In light of increased business uncertainties, as per our Research Note dated 11/10/11 and titled "Report Puts BRLI Under High-Powered Microscope", in which we referenced an article by TheStreetSweeper, an online research organization, we do not believe we are in a position to provide a recommendation on Bio-Reference Laboratories (BRLI). As a result, we are dropping coverage of the company effective immediately."
business uncertainties. The firm's latest rating was "Under Review" and our last price target was $21.
"In light of increased business uncertainties, as per our Research Note dated 11/10/11 and titled "Report Puts BRLI Under High-Powered Microscope", in which we referenced an article by TheStreetSweeper, an online research organization, we do not believe we are in a position to provide a recommendation on Bio-Reference Laboratories (BRLI). As a result, we are dropping coverage of the company effective immediately."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Calix (CALX) to Hold
- First Cash Financial (FCFS) PT Lowered to $140 at TD Cowen
- Tyler Tech (TYL) PT Raised to $500 at Oppenheimer
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
